Novatas Medipharma Private Limited - Company Profile

It is a healthcare private limited company based in Dehradun, Uttarakhand, India, established in 2014.
2014 Dehradun, Uttarakhand, India Active
Last Updated:
Access Report
About Novatas Medipharma Private Limited

Novatas Medipharma Private Limited, a active private limited company, was established on 07 February 2014 in Dehradun, Uttarakhand, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U24232UR2014PTC001025. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Bhupendra Singh (Director), Sheetal Panwar (Director). Past directors included Harender Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No. 241, Street No. 8, Lane No. 5 Rajinder Nagar, Dehradun, Uttarakhand, 248001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232UR2014PTC001025

  • Registration Number

    001025

  • Incorporation Date

    07 February 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Uttarakhand

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 3 Days
  • Last Filing with ROC 31 Mar 2024
Company report

Novatas Medipharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novatas Medipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Novatas Medipharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhupendra Singh Director 07 Feb 2014 Current
Sheetal Panwar Director 06 Jul 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Feb 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novatas Medipharma.

Novatas Medipharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Novatas Medipharma revenue growth over time
Novatas Medipharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novatas Medipharma?

In 2017, Novatas Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Novatas Medipharma?

Unlock and access historical data on people associated with Novatas Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novatas Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novatas Medipharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novatas Medipharma
Recent Activity within the Organization
  • Annual General Meeting

    Novatas Medipharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Novatas Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was documented.

  • Director Appointment

    The activity Sheetal Panwar was appointed as a Director was appointed as a Director on 06 Jul 2020 & has been associated with this company since 5 years 7 months . was completed.

  • Director Appointment

    The activity Bhupendra Singh was appointed as a Director was appointed as a Director on 07 Feb 2014 & has been associated with this company since 12 years 3 days . was completed.

  • Company Incorporation

    Novatas Medipharma Private Limited was registered on 07 Feb 2014 with Roc Uttarakhand & aged 12 years 3 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novatas Medipharma Private Limited?

The CIN of Novatas Medipharma Private Limited is U24232UR2014PTC001025.

Where is Novatas Medipharma Private Limited headquartered?

Novatas Medipharma Private Limited is headquartered at House No. 241, Street No. 8, Lane No. 5 Rajinder Nagar, Dehradun, Uttarakhand, 248001.

When was Novatas Medipharma Private Limited incorporated?

Novatas Medipharma Private Limited was incorporated on 07 February 2014.

Who are the current directors of Novatas Medipharma Private Limited?

The current directors of Novatas Medipharma Private Limited are

What is the primary industry of Novatas Medipharma Private Limited?

The primary industry of Novatas Medipharma Private Limited is Hospital And Medical Care.

Is Novatas Medipharma Private Limited a listed company?

Novatas Medipharma Private Limited is unlisted.

What is the capital structure of Novatas Medipharma Private Limited?

The authorized capital of Novatas Medipharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Novatas Medipharma Private Limited?

The compliance status of Novatas Medipharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available